FDA product code NBW: System, Test, Blood Glucose, Over The Counter

NBW is the FDA product code for system, test, blood glucose, over the counter. It is a Class II device, regulated under 21 CFR 862.1345 and reviewed by the Clinical Chemistry panel. FDA has cleared 514 510(k) submissions under NBW, 32 in the last five years, from 131 different applicants. The average 510(k) review took 195 days (median 153); 214 days on average over the last three years. FDA has posted 137 recalls for NBW devices, 9 initiated in the last five years.

Classification

FieldValue
Device nameSystem, Test, Blood Glucose, Over The Counter
Device classClass II
Regulation21 CFR 862.1345
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)

510(k) clearances per year for NBW

YearClearancesAvg. review days
201725258
201819167
201910153
20207145
20217416
202212426
20235264
20247263
20252198
20266180

Compare with all 510(k) review times · Search every NBW clearance

Top NBW applicants

ApplicantClearancesLatest
Taidoc Technology Corporation652022-06-16
I-Sens, Inc.222026-10-02
Bionime Corporation182024-11-04
Apex BioTechnology Corp.182022-12-21
Abbott Diabetes Care, Inc.182017-09-27

126 more applicants have NBW clearances. See the full list in Caduvo.

Most recent NBW clearances

510(k)ApplicantDeviceDecision dateReview days
K260738Changsha Sinocare, Inc.Safe AQ Easy Blood Glucose Monitoring System; Safe AQ Care Blood Glucose Monitoring System2026-10-30238
K261293EPS Bio Technology Corp.EASYMAX Voice Blood Glucose Monitoring System2026-10-23186
K260687Vivachek Biotech (Hangzhou) Co., Ltd.VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual Monitoring System.2026-10-09220
K260689I-Sens, Inc.CVS Advanced PLUS Blood Glucose Monitoring System2026-10-02213
K260545Ascensia Diabetes CareCONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System; CONTOUR® NEXT ONE Blood Glucose Monitoring System2026-08-27190

Recalls for NBW devices

137 product recalls in 75 recall events; 9 initiated in the last five years and 18 still open. Most recent: 2026-02-06.

YearRecalls
20172
20182
201916
20201
20214
20221
20231
20241
20252
20264

Frequently asked questions

What is FDA product code NBW?

NBW is the FDA product code for system, test, blood glucose, over the counter. It is a Class II device, regulated under 21 CFR 862.1345 and reviewed by the Clinical Chemistry panel.

What device class is NBW?

Class II, regulation 21 CFR 862.1345. Typical premarket route: 510(k).

How long does a 510(k) take for product code NBW?

Across 514 cleared submissions the average was 195 days from receipt to decision (median 153).

Which companies have the most NBW clearances?

Taidoc Technology Corporation (65); I-Sens, Inc. (22); Bionime Corporation (18); Apex BioTechnology Corp. (18); Abbott Diabetes Care, Inc. (18).

Have NBW devices been recalled?

Yes: 137 product recalls across 75 recall events; the most recent began 2026-02-06.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times